Medicine
Lynkuet 60 mg capsule
Lynkuet 60 mg capsule is a prescription medicine containing Elinzanetant for oral use, marketed by Bayer HealthCare Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F) with excursions permitted from 15°C to…
Key facts
- Active ingredient (INN)
- Elinzanetant
- Brand
- Lynkuet
- Strength
- 60 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 5 blister pack, 1 blister pack
- Marketing authorisation holder
- Bayer HealthCare Pharmaceuticals
- Manufacturer
- Bayer HealthCare Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F) with excursions permitted from 15°C to 30°C (59°F to 86°F). Store the remaining capsule in the original blister card in the carton until the next dose.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- G02CX07 Elinzanetant
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 24 October 2025
- Identifiers
- RxCUI 2725516, 2725522DailyMed set ID f42884ff-7dff-419c-8a0c-affe2ed73818NDC 50419-475Application NDA219469
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 5 blister pack in 1 carton / 12 capsule in 1 blister pack | 50419-475-05 | Bayer HealthCare Pharmaceuticals | 24 October 2025 |
| 1 blister pack in 1 carton / 12 capsule in 1 blister pack | 50419-475-73 | Bayer HealthCare Pharmaceuticals | 7 May 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Elinzanetant is a prescription medicine indicated for the treatment of moderate to severe vasomotor symptoms (VMS) due to menopause. It is available as capsules for oral use. MedsAcross supplies Elinzanetant for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ElinzanetantFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- LYNKUET prescribing information (Bayer HealthCare Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Lynkuet: European public assessment report (EPAR) · European Medicines Agency
Need Lynkuet 60 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.